This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The post Astellas Pharma CEO Q&a (Part 2): We Have To Have Alternatives for PrescriptionMedicine Business appeared first on MedCity News. In part 2 of our Q&A, Okamura addresses the need for biopharma companies to leverage digital technologies in disease management.
To ramp up its food-as-medicine support, NationsBenefits has acquired Good Measures, a company that offers coaching and personalized food prescriptions. The post NationsBenefits Acquires Good Measures to Advance Food-as-Medicine Offerings appeared first on MedCity News.
Medicine Cabinet, a new solution by GoodRx, gives users reminders to take their medications and refill prescriptions and recommends pharmacies based on prescription costs. It also has a rewards system for using GoodRx coupons and picking up prescriptions on time.
Weaving companionship into health care as we would a blockbuster drug can help us circumvent expensive healthcare services like emergency department visits and hospitalizations.
anti-kickback law that the drugmaker said prevented it from helping heart failure patients, many with low incomes, afford the medicine that costs $225,000 annually. For many, these coupons represent the difference between filling a prescription and going without lifesaving care, but there is a lot more here than just a co-pay coupon.
Many have never heard of a pharmacy benefit manager, mega-profitable companies that control what consumers pay for prescription drugs. The FTC’s new probe needs to go far to change the status quo.
The company and the European Medicines Agency warned European healthcare providers to continue limiting new patient prescriptions until the shortages let up.
The market for prescriptionmedicines in the United States was subject to major shifts in use across therapeutic areas in 2022, reflecting changes in patient health needs, the development, and availability of novel medicines, and complex market dynamics.
You can provide the best care possible inside the four walls of your hospital, but if your patients cant afford their prescriptions after you discharge them, the system isnt working. The post The Cost of Medication Non-Adherence How Hospitals Can Close the Gap through Better Communication appeared first on MedCity News.
Foodsmart is rolling out its new program that enables doctors to refer their patients to Foodsmart’s dieticians and healthy eating platform, as well as write prescriptions for healthy food just as easily as they might a normal pharmacy prescription.
As prescription drug abuse has grown in the US and Europe, the diversion of such treatments from legitimate sources has also increased. Drug diversion is the channelling of prescription drugs from a medical source into the illegal market. The post The rise of prescription drug abuse and drug diversion appeared first on.
They’ll be able to do this on the same platform they use to request non-emergency medical transportation and prescription delivery. Providers and payers will be able to use Uber Health to deliver healthy groceries and over-the-counter items to patients who need them.
When they say compare prescription drug prices, they mean the cost of a prescription if you aren’t using insurance. Do you want your employer, or your insurance company, or anyone else to know you’re on anti-depressants, HIV medication, Viagra, or that you regularly get medicine for genital warts? And advertising?
CVS Health intentionally prevented certain Medicare beneficiaries from accessing less expensive, generic prescriptions, according to a whistleblower lawsuit from a former senior CVS executive.
SUMMARY: Medicare spent nearly $600 million over a three-year period to pay for four cancer drugs with no clinical benefit an analysis published Monday by JAMA Internal Medicine found.
According to a study in the Journal for American Board of Family Medicine “respondents (76%) said they were likely to ask a health care provider about advertised drugs; 26% said they had already done so. Online research is used to evaluate new prescription drugs. A great example of poorly timed DTC is Humira.
GSK said it plans to cease commercialization of its prescriptionmedicines and vaccines in Nigeria, with the intent to switch to a third-party direct distribution model. After charting a similar move in Kenya last year, GSK is pulling the plug on its Nigerian operations. |
SUMMARY: Online health seeker numbers are still very high, indicating that people are doing their research first before asking for a prescription drug. Online ads for prescription drugs are unique. Nobody will see an online ad for a prescription drug and ask their doctor about it without doing some research first.
These cost estimates include cancer-attributable costs for medical services and oral prescription drugs. According to a team of Penn State College of Medicine researchers, care for the 15 most prevalent types of cancer in the U.S. National costs for cancer care were estimated to be $190.2 billion in 2015 and $208.9 population.
Ed Silverman in STAT News wrote “as states struggle to control the cost of prescriptionmedicines, a new report found pharmacy benefit managers pocketed more than $89 million collected on behalf of the Florida Medicaid program — and the consultants who ran the analysis recommended state officials rework the arrangements.
So, here are three “best guesses” for what 2023 will hold for the off-patent medicines segment — which accounts for roughly 70% of medicines prescribed worldwide (including the vast majority of system-critical antibiotics and ICU therapies), but only about 20% of the total cost.
Among adults 65 and older with Medicare coverage, average annual out-of-pocket costs for medical services and prescription drugs were highest in the initial phase of care (first 12 months after diagnosis) — $2,200 and $243, respectively — and the end-of-life phase (12 months before death) — $3,823 and $448, respectively.
Mounjaro’s homepage is a callout about patients losing “up to 25 pounds” Is Lilly responsible for informing patients that using this drug requires a diet modification, and doesn’t that someone can order a double quarter pounder at McDonald’s after using the medicine? The post Uniqueness if pharma DTC.
The US Senate has come together to pass a bill that aims to prevent pharma companies from filing multiple patents around biologic drugs as a way to delay biosimilar competitors.Lawmakers unanimously passed the Affordable Prescriptions for Patients Act of 2023 (S-150), which is part of a lengthening list of measures being taken by Congress to curb the (..)
Did you know not all medicines in Malaysia need a prescription? You know how we’re always told to see a doctor before taking certain medicines? Some medications that are supposed to need a prescription – like antibiotics – can still be bought over the counter at smaller pharmacies. Is it the right medicine?
Research published in the New England Journal of Medicine shows that a value-based healthcare model can help solve the cost and quality problems that plague the U.S. Prescription drugs costs are just a small part of healthcare costs (11%). health care system. Value-based models encourage a team-oriented approach to patient care.
Have you ever gone to a pharmacy with a prescription, only to find out the medicine isn’t in stock? When a pharmacist recommends an alternative, they’re using their expertise to find a medicine that works the same way as the one you were prescribed. It’s a bit of a letdown, right? What Does It Mean to Recommend an Alternative?
Researchers with Aimed Alliance , a non-profit that seeks to protect and enhance the rights of health care consumers and providers, say that doctors are so fed up with the constant headaches caused by insurers that two-thirds would recommend against pursuing a career in medicine. Nearly half (48%) are considering a career change altogether.
prices on seven of the 10 costliest prescription drugs in 2020 without justification, increasing drug spending by $1.67 group that reviews the value of medicines said on Tuesday. According to Reuters “drugmakers hiked U.S. billion, a U.S. leading to an almost $1.4 billion increase in U.S. The total impact on U.S.
One-quarter of all cancer patients chose not to fill a prescription due to cost, according to a 2013 study in The Oncologist. According to a study published in the American Journal of Medicine, more than 42 percent of the 9.5 million people diagnosed with cancer from 2000 to 2012 drained their life’s assets within two years.
The cost of Humira, which is injected via syringe, was more than $72,000 a year on prescription drug websites this week and is not expected to come down until at least 2023. AbbVie has filed for 165 patents on Imbruvica, and officials have granted 88 of them, the Initiative for Medicines, Access & Knowledge reports.
The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has approved Colonis Pharma’s melatonin oral solution for the treatment of sleep-onset insomnia in children and adolescents with attention-deficit hyperactivity disorder (ADHD). Prescription-only vs OTC. Colonis Pharma is a subsidiary company within Clinigen.
Guidance on the way pharma companies communicate about prescriptionmedicines has been updated in the UK to cover use of social media channels for the first time. “With its wide reach and international audience, information on medicines can be seen by audiences it wasn’t intended for.”
Novo Nordisk has admitted that it would not be able to keep up, adding that it would likely take until early 2022 for the supply to stabilize and that some patients “are experiencing an approximate one month or longer delay in filling prescriptions for Wegovy.”
Sam Crowther, founder and CEO of cybersecurity company Kasada, tells us about a recent discovery his company made that revealed tens of thousands of accounts with prescription drug attachments in major online pharmacies had been compromised. So, suppose I want to go and buy some Oxycodone, Adderall, or any other prescription painkiller.
According to KFF, “ the cost of health care often prevents people from getting needed care or filling prescriptions. Three in ten (29%) also report not taking their medicines as prescribed at some point in the past year because of the cost. Half of U.S. As t stands now, our healhealthcaretem is too profitable.
Patients in the US want to see a broader sense of urgency in the development of new medicines for non-COVID conditions relevant to their own lives. However, the public is aware that they may need prescription drugs to manage chronic health conditions. Even patients will still line up if a prescription drug shows promise.
Pharma companies are still too focused on profits while people continue to rely on prescription drugs to compensate for unhealthy lifestyles. While pharma continues to advertise help for prescription drug prices, 25% of people say they can’t afford their medications. Are prescription drugs priced too high?
While not a panacea, these technologies can be part of a comprehensive set of solutions that help close the gap of inequity in medicine and drug development.
Pfizer CEO Albert Bourla, Ph.D., is in trouble for "misleading" and "overly promotional" claims he made during a BBC interview late last year about their COVID-19 vaccine for younger kids, which was not approved at the time.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content